Thrombolysis with tissue-type plasminogen activator in acute myocardial infarction. Potentials and pitfalls.
Jaffe
A S
AS
Sobel
B E
BE
D000818:Animals; D002986:Clinical Trials as Topic; D003326:Coronary Circulation / Q000187:drug effects; D004562:Electrocardiography; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D009200:Myocardial Contraction; D009203:Myocardial Infarction / Q000188:drug therapy*; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use
D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator